![Lauren DAngelo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lauren DAngelo
Directeur des opérations chez
ALPHA COGNITION INC.
Fortune : 1 M $ au 30/09/2026
Profil
Lauren DAngelo is currently Chief Operating Officer at Alpha Cognition, Inc. since 2023.
Formerly, Ms. DAngelo was Vice President-Marketing & Commercial Strategy at Urovant Sciences, Inc. from 2017 to 2021.
Education includes an undergraduate degree from Florida State University and an MBA from the University of Florida.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COGNITION INC 0,65 % | 19/05/2026 | 140 695 ( 0,65 % ) | 1 M $ | 30/09/2026 |
Postes actifs de Lauren DAngelo
| Sociétés | Poste | Début |
|---|---|---|
| ALPHA COGNITION INC. | Directeur des opérations | 01/01/2023 |
Anciens postes connus de Lauren DAngelo
| Sociétés | Poste | Fin |
|---|---|---|
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Sales & Marketing | 01/05/2021 |
Formation de Lauren DAngelo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Florida State University
 Florida State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Urovant Sciences, Inc.
Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies for urologic conditions | Health Technology |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
